Considering the clinical course and the morphological alterations of the retina, in which cells are progressively involved until they become completely dysfunctional, it is possible to hypothesize that some forms of RP, such as those linked to the RPE65 gene mutation, could benefit from gene therapy if carried out in patients at an early stage of the disease. Here, RPE65 is linked to retinitis pigmentosa 1.